Vaccinex Q2 EPS $(0.12) Up From $(0.13) YoY
Portfolio Pulse from Benzinga Newsdesk
Vaccinex (NASDAQ:VCNX) reported Q2 losses of $(0.12) per share, a 7.69% improvement from $(0.13) per share losses in the same period last year.
August 14, 2023 | 12:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Vaccinex reported a 7.69% improvement in its Q2 losses per share YoY. This could indicate a positive trend in the company's financial performance.
Vaccinex's Q2 losses per share have improved by 7.69% compared to the same period last year. This could indicate a positive trend in the company's financial performance, which may positively impact the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100